No Data Yet
Despite a broad chemical industry downturn in 2025, Albemarle, Perimeter Solutions, and Sociedad Quimica y Minera posted six-month gains of over 100%, positioning them for continued growth.
Aramark has successfully repriced its $2.4 billion Term Loan B, capitalizing on a favorable interest rate environment to lower its borrowing costs. The move underscores a broader trend of corporations optimizing balance sheets following recent shifts in central bank policy.
CorMedix has acquired Melinta Therapeutics for $300 million, a strategic move to diversify its product portfolio beyond its primary revenue driver, DefenCath. The acquisition leverages strong sales performance and reflects a broader trend of targeted M&A across the pharmaceutical and medical technology sectors.
Perimeter Solutions (NYSE: PRM) will acquire Medical Manufacturing Technologies (MMT) for $685 million in an all-cash transaction. The deal significantly expands PRM's presence in the specialized medical device manufacturing sector, continuing its acquisitive growth strategy.
Portfolio
